Inactivating germline mutations in the tumor suppressor kinaseLKB1(STK11) predispose to Peutz-Jeghers Syndrome (PJS) with increased cancer risk and early-onset development of gastrointestinal polyps requiring regular surveillance. Studies using PJS mouse models have indicated fibroblasts as drivers of polyp formation. Here, we use single-cell RNA sequencing to investigate the fibroblast heterogeneity and tumorigenic mechanisms in a PJS mouse model. We identify five distinct gastric fibroblast subsets, including a polyp-enriched ST2 (Il1rl1)-expressing crypt top fibroblast (CTF) cluster, and show that the polyps arise fromFoxl1-expressing CTFs. The transcriptional signature of the ST2+fibroblasts overlapped with the effects seen by LKB1 lossin vitroandin vivo. The ST2+fibroblasts also shared similarities with inflammation-associated fibroblasts, and inflammation exacerbated polyposis. Interestingly, the tumorigenic ST2+fibroblasts showed a distinct signaling pattern, including high expression of interleukin 11 (IL-11). Notably, IL-11 was required for the LKB1 loss-induced transcriptional changes in fibroblasts, and treatment with an IL-11 neutralizing antibody substantially reduced the tumor burden in the PJS mouse model, suggesting therapeutic value. In summary, our study uncovers a critical mechanism underlying PJS polyposis and suggests that PJS patients could benefit from anti-IL-11 therapy.